Drug firm Vivimed Labs today reported a 29.76 per cent dip in its consolidated net profit at Rs 12.60 crore for the quarter ended March.
The company had posted a net profit of Rs 17.94 crore in the January-March period of 2014-15 fiscal, Vivimed Labs said in a BSE filing.
Consolidated total income from operations of the company stood at Rs 350.04 crore in the same period of the 2015-16 fiscal as against Rs 356.71 crore in the year-ago period.
For the full fiscal, it posted a net profit of Rs 83.67 crore as against Rs 72.05 crore in 2014-15.
The company's consolidated total income from operations stood at Rs 1,356.43 crore in 2015-16 fiscal compared with Rs 1,385.96 crore in the preceding year.
In a separate filing, the company said its board has not recommended any dividend for the 2015-16 fiscal.
Vivimed Labs shares today ended 6.78 per cent down at Rs 77.70 on BSE.
